CATALYST PHARMACEUTICALS INC (CPRX)
US14888U1016 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 65.12M | 71.41M | 83.10M | 39.50M | 75.00M | |||
| Depreciation Amortization | 35.71M | 32.88M | 1.20M | 200.00K | 100.00K | |||
| Income Taxes - Deferred | -18.06M | -17.82M | 4.90M | 9.30M | -33.00M | |||
| Change In Working Capital | -20.27M | -37.32M | 13.70M | 5.00M | -4.10M | |||
| Interest Paid | N/A | 705.00K | N/A | N/A | N/A | |||
| Taxes Paid | N/A | 50.46M | -7.70M | N/A | N/A | |||
| Other non cash items | 100.96M | 94.45M | 13.10M | 6.40M | 7.00M | |||
| OPERATING CASH FLOW | 163.43M | 143.60M | 116.00M | 60.40M | 45.00M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -330.00K | -231.00K | 0.00 | -1.00M | 0.00 | |||
| Other Investing Activity | -130.97M | -293.27M | 9.20M | -10.00M | -5.00M | |||
| INVESTING CASH FLOW | -131.30M | -293.50M | 9.20M | -11.00M | -5.00M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 144.01M | 2.79M | 2.70M | -8.00M | 800.00K | |||
| Other Financing Activity | -14.02M | -13.65M | -1.00M | -200.00K | -100.00K | |||
| FINANCING CASH FLOW | 130.09M | -10.86M | 1.70M | -8.10M | 700.00K | |||
| CHANGE IN CASH | 162.22M | -160.76M | 126.90M | 41.30M | 40.70M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 163.43M | 143.60M | 116.00M | 60.40M | 45.00M | |||
| Capital Expenditure | -330.00K | -231.00K | 0.00 | -1.00M | 0.00 | |||
| FREE CASH FLOW | 163.09M | 143.37M | 116.00M | 59.40M | 45.00M | |||
All data in USD